Vertex Pharmaceuticals Incorporated · VRTX
As of the latest run, Vertex Pharmaceuticals Incorporated (VRTX) scores 60/100 overall — a broadly solid profile. Its strongest dimension: risk control (79/100); the one that most warrants attention: momentum (45/100).
Three pillars judge the company (profitability, growth, financial health), three judge the stock (valuation, momentum, risk). The score is recomputed every day from Yahoo Finance market data — the one shown above reflects today's state.
The risk pillar comes in at 79/100 — volatility kept in check by market standards. Growth comes in at 75/100 — sustained revenue growth. Profitability comes in at 62/100 — above-average margins and return on capital.
The breakdown of each pillar — and a plain-English explanation of what it measures — is available in the full analysis, free and updated every day.
No pillar drops below the watch threshold (45/100) at the latest run.
No score replaces your own judgment: Stock Analyzer is a tool for analysis and understanding, not investment advice.